Environmental protection

Managing our environmental impact across all our activities and products



of our total electricity use is sourced or generated from renewable sources

CDP A lists

for Water Security and Climate Change for the third consecutive year, for our actions and disclosures on climate change and water stewardship

$19 million

invested in environmental efficiency projects (NRRGG Fund)


of active pharmaceutical ingredient (API) discharges from suppliers demonstrated as safe


reduction in our water use since 2015


of recycling as total waste

Our approach

Our Environmental Protection approach follows the science. We set science-based emissions reduction targets and were one of the first companies in the FTSE 350 to have them approved by the . Our scope 1 and 2 greenhouse gas emissions targets are consistent with reductions required to keep warming to 1.5°C, what the latest climate science has told us is needed to prevent the most damaging effects of climate change, and our scope 3 target is in line with current best practice.

We know that by investing in new product design, clean technologies, and more efficient processes, we will save money and resources. These investments build resilience in the face of dwindling natural resources, a growing global population, and more frequent and severe climate-related weather events.


Our Environmental Protection focus areas include:

Our Environmental protection approach supports the following Sustainable Development Goals (SDGs)

Our stories

Read more about Environmental protection in our Sustainability Report.

To view our policies, standards and positions, visit our Resources page.

Environmental risk data relating to our medicines

Here you can find an overview of the environmental risk of AstraZeneca’s medicines. This information will be updated, if appropriate, as new data becomes available. See Environmental risk data relating to our medicines